Does obesity change the effect of aromatase inhibitors (AIs) on estradiol, leptin, insulin, and IGF-1 serum levels in breast cancer patients?

Artac, MehmetAskin, DuduKiyici, AyselEren, Onder OrhanOncel, MufideBoruban, Melih CemBozcuk, Hakan Sat2024-02-232024-02-2320120732-183X1527-7755https://hdl.handle.net/20.500.12452/1730348th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -- JUN 01-06, 2012 -- Chicago, IL[Abstract Not Availabe]eninfo:eu-repo/semantics/closedAccess[Keyword Not Available]Does obesity change the effect of aromatase inhibitors (AIs) on estradiol, leptin, insulin, and IGF-1 serum levels in breast cancer patients?Conference Object3015Q1WOS:000318009800272Q1